Search results for: Henry G. Grabowski
Filter search results
Biosimilars and Data Exclusivity
8 June 2010
…FDA determination of ‘interchangeablility’. Henry G. Grabowski is Professor Emeritus and Director of the Program in Pharmaceutical Health Economics, Duke University. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J….
OHE Lunchtime Seminar and Webinar with Professor David Grabowski: Interventions that Encourage High-Value Nursing Home Care: Lessons for the UK
21 March 2017
Professor David Grabowski from Harvard University will lead an OHE Lunchtime Seminar on 19 April 2017 on the topic of interventions that encourage high-value nursing home care: lessons for the…
Lancelot Henry de Frahan – 2022 Prize Finalist
18 January 2023
Dr. Lancelot Henry de Frahan, PhD, post–doctoral researcher at the Economics department at the University of Chicago. His research specializes in price theory, labor economics and public finance with a…
Henry Fong
2 October 2024
Henry joined OHE in October 2024 as a Graduate Economist. He holds an MPharm degree from University College London and is a registered pharmacist with the General Pharmaceutical Council (GPhC)….
New OHE Seminar Briefing: Interventions that Encourage High-value Nursing Home Care: Lessons for the UK
11 August 2017
…Grabowski from Harvard University. In this briefing Professor Grabowski explains that both the US and UK devote significant financial resources to nursing home care, and both have relied on regulation…
Biosimilar Competition: Lessons from Europe and Prospects for the US
2 December 2014
Based on an OHE lunchtime seminar by Professor Henry Grabowski, this seminar briefing explores the lessons learned from Europe’s experience with biosimilars, and provides an analysis of how the US…
Biosimilar Competition: Lessons from Europe and Prospects for the US
14 March 2014, 12:00am
At this OHE Lunchtime Seminar, Professor Henry Grabowski presented the results of his recent research on competition in five European countries on Eprex® (epoetin alpha) and Neupogen® (filigrastim) and their…